Prevention of Nonvertebral Fractures With Oral Vitamin D and Dose Dependency

Heike A. Bischoff-Ferrari, Walter C. Willett, John B. Wong, Andreas E. Stuck, Hannes B. Staehelin, E. John Orav, Anna Thoma, Douglas P. Kiel, Jana Henschkowski
2009 Archives of Internal Medicine  
Antifracture efficacy with supplemental vitamin D has been questioned by recent trials. Methods: We performed a meta-analysis on the efficacy of oral supplemental vitamin D in preventing nonvertebral and hip fractures among older individuals (Ն65 years). We included 12 double-blind randomized controlled trials (RCTs) for nonvertebral fractures (n=42 279) and 8 RCTs for hip fractures (n=40 886) comparing oral vitamin D, with or without calcium, with calcium or placebo. To incorporate adherence
more » ... treatment, we multiplied the dose by the percentage of adherence to estimate the mean received dose (doseϫadherence) for each trial. Results: The pooled relative risk (RR) was 0.86 (95% confidence interval [CI], 0.77-0.96) for prevention of nonvertebral fractures and 0.91 (95% CI, 0.78-1.05) for the prevention of hip fractures, but with significant heterogeneity for both end points. Including all trials, antifrac-
doi:10.1001/archinternmed.2008.600 pmid:19307517 fatcat:buoliaxkuvbrhcrqyooqmvftfe